Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates (Q42225564)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 April 2014
edit
Language Label Description Also known as
English
Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates
scientific article published on 10 April 2014

    Statements

    Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates (English)
    Darren A Murrey
    Bartholomew J Naughton
    F Jason Duncan
    Aaron S Meadows
    Katie J Campbell
    William G Bremer
    Christopher M Walker
    Laurie Goodchild
    Krista La Perle
    Douglas M McCarty

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit